These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1019540)

  • 1. Preliminary studies on the antischistosomal activity of topically applied oxamniquine.
    Pellegrino J; Gilbert B; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(6):456-8. PubMed ID: 1019540
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials with oxamniquine, by oral route, in schistosomiasis mansoni.
    Katz N; Grinbaum E; Chaves A; Zicker F; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):371-7. PubMed ID: 794980
    [No Abstract]   [Full Text] [Related]  

  • 3. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxamniquine dosage in Malawi.
    Teesdale CH; Chitsulo L; Pugh RN
    East Afr Med J; 1984 Jan; 61(1):40-4. PubMed ID: 6745140
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of intestinal bilharziasis with oral oxamniquine (a preliminary report).
    Koura M; Gaber A; Abdel-Meguid M; Saif M
    J Egypt Med Assoc; 1975; 58(5-6):287-95. PubMed ID: 821982
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary laboratory trials with oxamniquine as a prophylactic agent in schistosomiasis.
    Pellegrino J; Pereira LH; Mello RT
    Rev Inst Med Trop Sao Paulo; 1976; 18(2):97-101. PubMed ID: 1273410
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.
    Creasey AM; Taylor P; Thomas JE
    Cent Afr J Med; 1986 Jul; 32(7):165-7. PubMed ID: 3107836
    [No Abstract]   [Full Text] [Related]  

  • 8. A field evaluation of three dose levels of oxamniquine in Gezira--Sudan.
    Abdel-Rahim IM; Haridi AA; Abdel-Hameed AA
    East Afr Med J; 1988 Nov; 65(11):771-7. PubMed ID: 3150352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trial schistosomiasis control in an endemic area by 4 mass treatments of the population].
    Silva AE; Rocha L; Castro CN; Prata A
    Rev Inst Med Trop Sao Paulo; 1981; 23(6):260-3. PubMed ID: 7345537
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxamniquine treatment in experimental schistosomiasis mansoni. Biological, morphological and pathological changes induced by divided doses.
    Mikhail EG; Sabet S; Mahran SG; Gaber AA; Soliman AA; Zaki IE; Tadros MB
    J Egypt Soc Parasitol; 1981 Jun; 11(1):33-49. PubMed ID: 7299160
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-finding trials of oral oxamniquine in Rhodesia.
    de V Clarke V; Blair DM; Weber MC; Garnett PA
    S Afr Med J; 1976 Oct; 50(46):1867-71. PubMed ID: 996687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in children in Ethiopia.
    Ayele T
    East Afr Med J; 1986 Apr; 63(4):291-4. PubMed ID: 3089756
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxamniquine in the prevention of bilharzial infection.
    Jewsbury JM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):18-20. PubMed ID: 606372
    [No Abstract]   [Full Text] [Related]  

  • 15. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
    da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
    [No Abstract]   [Full Text] [Related]  

  • 16. Field use of oral oxamniquine in the treatment of S. mansoni.
    Eyakuze VM; Rutasitara WK; Ndalahwa JB
    East Afr Med J; 1979 Jan; 56(1):22-5. PubMed ID: 436702
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 18. A fifteen-month study on the efficacy of a single 15 mg/kg dose of oxamniquine (Vansil) in Schistosoma mansoni in an endemic area.
    Nozais JP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):52-7, 168-74. PubMed ID: 6256843
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis, and in vivo evaluation of oxamniquine methacrylate and acrylamide prodrugs.
    Filho RP; de Souza Menezes CM; Pinto PL; Paula GA; Brandt CA; da Silveira MA
    Bioorg Med Chem; 2007 Feb; 15(3):1229-36. PubMed ID: 17134907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.